[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100638320":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":35,"locations":40,"responsibleParty":58,"collaborators":60,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":25,"eligibilityCriteria":69,"healthyVolunteers":66,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":25,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":87,"whyStopped":25,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Children's Hospital Los Angeles","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Control","ACTIVE_COMPARATOR","Recontacting patients by a nurse case manager after transition launch to determine transition success.",[13],"Behavioral: Control",{"label":15,"type":16,"description":17,"interventionNames":18},"Navigation","EXPERIMENTAL","Patients in the intervention have phone or video session with patient navigator at enrollment, 6, 12 and 18 months, or more frequently as dictated by high-risk social needs.",[19],"Behavioral: Navigation",[21,26],{"type":22,"name":15,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","Follow Up",[15],null,{"type":22,"name":9,"description":27,"armGroupLabels":28,"otherNames":25},"Standard of Care",[9],[30,33],{"name":31,"affiliation":5,"role":32},"David Freyer, DO, MS","PRINCIPAL_INVESTIGATOR",{"name":34,"affiliation":5,"role":32},"Kimberly Miller, PhD",[36],{"name":31,"role":37,"phone":38,"phoneExt":25,"email":39},"CONTACT","(323) 361-6695","DFreyer@chla.usc.edu",[41],{"facility":5,"status":25,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Los Angeles","California","90027","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-118.24368,34.05223,{"lat":51,"lon":50},[54,55,56],{"name":31,"role":37,"phone":25,"phoneExt":25,"email":25},{"name":31,"role":32,"phone":25,"phoneExt":25,"email":25},{"name":34,"role":57,"phone":25,"phoneExt":25,"email":25},"SUB_INVESTIGATOR",{"type":32,"investigatorFullName":31,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Medical Staff\u002FUSC Faculty CWR",[61],{"name":62,"class":63},"National Cancer Institute (NCI)","NIH","100638320","patient-navigation-for-improving-transition-success-among-multiply-disadvantaged-young-adult-survivors-of-childhood-cancer-100638320",false,"NCT07630831","Patient Navigation for Improving Transition Success Among Multiply Disadvantaged Young Adult Survivors of Childhood Cancer","Inclusion Criteria:\n\n* diagnosed between the ages of 0-19 years with cancer or with any condition treated with cancer-like therapy.\n* currently in follow up at survivorship clinic or had a survivorship launch visit during the 12 months prior to study activation.\n* current age 20-29 (\\>95% of patients will be age 20-21)\n* meet LIFE Clinic transition readiness criteria, as clinically applied:\n* at least 5 years off treatment\n* medically stable\n* demonstrate a workable understanding of transition\n* have an identified primary care provider\n* able to speak and read English or Spanish\n* can provide informed consent.\n\nExclusion Criteria:\n\n* do not meet transition criteria\n* speak a language other than English or Spanish\n* are significantly impaired and cannot provide informed consent.","ALL","20 Years","29 Years",{"count":74,"type":75},190,"ESTIMATED","INTERVENTIONAL",[78],"NA","The goal of this clinical trial is to improve the successful healthcare transition from pediatric to adult-focused care for childhood cancer survivors. The main questions it aims to answer are\n\n* Receipt of the intervention (vs. standard of care control) will increase the proportion of CCS achieving transition success to adult-focused survivorship care from 50% to 70%.\n* Receipt of the intervention (vs. standard of care control) will significantly reduce patients' unmet HRSN.\n* Intervention effectiveness will be moderated by sociodemographic factors (gender, race\u002Fethnicity, insurance status), medical risk for late effects, HRSN burden, and patient-reported outcomes (quality of life, self-efficacy).\n\nResearchers will compare those that receive intervention versus standard of care.\n\nPatients are randomized to either an intervention group, receiving structured PN-led sessions and tailored support for care transitions, or a control group receiving standard follow-up by a nurse case manager. High-HRSN patients in the intervention arm get monthly check-ins and coordinated handoffs to adult care providers for continuity.",[81],"Cancer Childhood",[83,84,85,86],"Childhood Cancer","Transition of care","Health-related social needs","Patient Navigation","NOT_YET_RECRUITING","2026-06-02",{"date":90,"type":91},"2026-06-05","ACTUAL",{"date":93,"type":75},"2026-07-01",{"date":95,"type":75},"2030-09-01",{"name":5,"class":6},1]